The Healthcare Stage I Episode 10 I A novel navigation system for ERCP procedure by Swift Duct

In this episode, we delve into the groundbreaking innovations of Swift Duct, an Israeli medical device company founded in 2020, with CEO Samer Abboud. Swift Duct is on a mission to transform Endoscopic retrograde cholangio-pancreatography (ERCP), a vital procedure aimed at and treating detecting biliary and pancreatic duct blockages.

Through a captivating discussion, we discuss how Swift Duct's cutting-edge navigation solution aims to revolutionize ERCP, promising easier, faster, and safer procedures. With a catheter boasting unique bending capabilities and a sensor-equipped guidewire, the company aims to streamline the process, reduce trial and error, and ultimately mitigate healthcare costs and patient suffering.

We discuss Swift Duct's journey from seed funding to successfully demonstrating their technology's proof of concept in preclinical trials. Join us to explore how Swift Duct's innovative approach stands to benefit over 2 million ERCP procedures annually and why this venture presents a compelling investment opportunity in the MedTech landscape.

If you're an investor seeking new prospects in the MedTech sector, tune in to gain insights into the potential future of ERCP and the promising advancements brought forth by Swift Duct.

Listen now on Spotify and Apple Podcast or view on “the Healthcare Stage" YouTuve channel, and stay ahead in the ever-evolving world of MedTech! 🚀

#TheHealthcareStage #MedTech #HealthcareInnovation  #ERCP #VC #Investment #Startup #SwiftDuct